Januvia and Cefazolin sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Januvia (sitagliptin phosphate) and Cefazolin sodium (cefazolin sodium). Common drug interactions include blindness unilateral among females and erythema multiforme among males.

The phase IV clinical study analyzes what interactions people have when they take Januvia and Cefazolin sodium. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.

What is Cefazolin sodium?

Cefazolin sodium has active ingredients of cefazolin sodium. eHealthMe is studying from 3,649 Cefazolin sodium users. Check the latest studies of Cefazolin sodium.

On Jul, 19, 2026

19 people who take Januvia and Cefazolin sodium together, and have interactions are studied.

Januvia and Cefazolin sodium drug interactions.

What are the common drug interactions of Januvia and Cefazolin Sodium, by gender? *:

female:

Blindness unilateral
Eye pain
Headache (pain in head)
Hospitalisation
Hypersensitivity
Alanine aminotransferase increased
Anaemia (lack of blood)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Aortitis (inflammation of the aortic wall)
Axillary pain

male:

Erythema multiforme (a type of hypersensitivity reaction)
Interstitial lung disease
Angina pectoris (chest pain due to ischemia of the heart muscle)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pyelonephritis acute (sudden inflammation of kidney caused by bacteria)
Drug eruption (adverse drug reaction of the skin)
Eosinophil count increased
Erythema (redness of the skin)

What are the common drug interactions of Januvia and Cefazolin Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Hypersensitivity
Migraine (headache)

50-59:

Alanine aminotransferase increased
Aortitis (inflammation of the aortic wall)
Axillary pain
Blood alkaline phosphatase increased
Constipation
Gastric ulcer (stomach ulcer)
Hypersensitivity
Insomnia (sleeplessness)
Iron deficiency anaemia
Neuropathy peripheral (surface nerve damage)

60+:

Papilloedema (optic disc swelling)
Blindness unilateral
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Blood glucose increased
Calculus ureteric (stone in ureter)
Cardiac failure
Drug eruption (adverse drug reaction of the skin)
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Eosinophil count increased

What are the existing conditions these people have? *

Insomnia (sleeplessness): 6 people, 31.58%
High Blood Pressure: 5 people, 26.32%
Type 2 Diabetes: 5 people, 26.32%
Pain: 4 people, 21.05%
Constipation: 3 people, 15.79%
Neuralgia (pain in one or more nerves): 3 people, 15.79%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 10.53%
Gastritis (inflammation of stomach): 2 people, 10.53%
Gastric Ulcer (stomach ulcer): 2 people, 10.53%
Abdominal Discomfort: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Januvia and Cefazolin sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously